José M. Peña - Publications, H-index & Citations

José M. Peña

Harvard University

29H指数

141论文数

3.3K被引数

收录论文 32

发表时间

Sex differences in global electrical heterogeneity: The Hispanic Community Health Study/Study of Latinos 全球电学异质性的性别差异：Hispanic Community Health Study/Study of Latinos

heart rhythm

IF2.9

2025-01-01

OAAI

Tereshchenko, Larisa G.; Haq, Kazi T.; Howell, Stacey J.; Mitchell, Evan C.; Hyde, Jessica; Martinez, Jesus; Ahmed, Cassandra A.; Briceno, Genesis; Patel, Hetal; Pena, Jose; Khan, Akram; Soliman, Elsayed Z.; Lima, Joao A. C.; Kapadia, Samir R.; Misra-Hebert, Anita D.; Kansal, Mayank M.; Daviglus, Martha L.; Kaplan, Robert

Latent profiles of global electrical heterogeneity: the Hispanic Community Health Study/Study of Latinos

EUROPEAN HEART JOURNAL - DIGITAL HEALTH

IF4.4

2024-07-08

OAAI

Tereshchenko, Larisa G.; Haq, Kazi T.; Howell, Stacey J.; Mitchell, Evan C.; Martinez, Jesus; Hyde, Jessica; Briceno, Genesis; Pena, Jose; Pocius, Edvinas; Khan, Akram; Soliman, Elsayed Z.; Lima, Joao A. C.; Kapadia, Samir R.; Misra-Hebert, Anita D.; Kattan, Michael W.; Kansal, Mayank M.; Daviglus, Martha L.; Kaplan, Robert

Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY

IF3.4

2017-07-28

PREAI

Soriano, Vicente; Benitez-Gutierrez, Laura; Arias, Ana; Carrasco, Itziar; Barreiro, Pablo; Pena, Jose M.; de Mendoza, Carmen

Drug interactions in HIV-infected patients treated for hepatitis C

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY

IF3.4

2017-07-13

PREAI

Soriano, Vicente; Labarga, Pablo; Fernandez-Montero, Jose V.; de Mendoza, Carmen; Benitez-Gutierrez, Laura; Pena, Jose M.; Barreiro, Pablo

Dual antiretroviral therapy for HIV infection

EXPERT OPINION ON DRUG SAFETY

IF3.1

2017-07-11

PREAI

Soriano, Vicente; Vicente Fernandez-Montero, Jose; Benitez-Gutierrez, Laura; de Mendoza, Carmen; Arias, Ana; Barreiro, Pablo; Pena, Jose M.; Labarga, Pablo

New antivirals for the treatment of chronic hepatitis B

EXPERT OPINION ON INVESTIGATIONAL DRUGS

IF4.1

2017-05-26

PREAI

Soriano, Vincent; Barreiro, Pablo; Benitez, Laura; Pena, Jose M.; de Mendoza, Carmen

Rate and predictors of serum HCV-RNA >6 million IU/mL in patients with chronic hepatitis C

JOURNAL OF CLINICAL VIROLOGY

IF3.4

2015-10-01

PREAI

Barreiro, Pablo; Labarga, Pablo; Fernandez-Montero, Jose V.; de Mendoza, Carmen; Benitez-Gutierrez, Laura; Pena, Jose M.; Soriano, Vicente

Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects

EXPERT OPINION ON DRUG SAFETY

IF3.1

2015-07-27

PREAI

Esposito, Isabella; Labarga, Pablo; Barreiro, Pablo; Fernandez-Montero, Jose V.; de Mendoza, Carmen; Benitez-Gutierrez, Laura; Pena, Jose M.; Soriano, Vicente

Emerging Challenges in Managing Hepatitis B in HIV Patients

CURRENT HIV/AIDS REPORTS

IF4.4

2015-07-09

PREAI

Soriano, Vincent; Labarga, Pablo; de Mendoza, Carmen; Pena, Jose M.; Fernandez-Montero, Jose V.; Benitez, Laura; Esposito, Isabella; Barreiro, Pablo

Drug interactions with new hepatitis C oral drugs

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY

IF3.4

2015-01-02

PREAI

Soriano, Vincent; Labarga, Pablo; Barreiro, Pablo; Fernandez-Montero, Jose V.; de Mendoza, Carmen; Esposito, Isabella; Benitez-Gutierrez, Laura; Pena, Jose M.

Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

CLINICAL INFECTIOUS DISEASES

IF7.3

2014-08-05

117

OAAI

Bastos, Mayara L.; Hussain, Hamidah; Weyer, Karin; Garcia-Garcia, Lourdes; Leimane, Vaira; Leung, Chi Chiu; Narita, Masahiro; Pena, Jose M.; Ponce-de-Leon, Alfredo; Seung, Kwonjune J.; Shean, Karen; Sifuentes-Osornio, Jose; Van der Walt, Martie; Van der Werf, Tjip S.; Yew, Wing Wai; Menzies, Dick

LDLr genotype modifies the impact of IL28B on HCV viral kinetics after the first weeks of treatment with PEG-IFN/RBV in HIV/HCV patients 在HIV/HCV患者中使用peg-ifn/RBV治疗的第一周后，LDLr基因型改变IL28B对HCV病毒动力学的影响

AIDS

IF3.1

2012-05-15

OAAI

Rivero-Juarez, Antonio; Camacho, Angela; Caruz, Antonio; Neukam, Karin; Gonzalez, Rafael; Di Lello, Federico A.; Perez-Camacho, Ines; Mesa, Pilar; Torre-Cisneros, Julian; Pena, Jose; Pineda, Juan A.; Rivero, Antonio

Central Neuropeptide Y Modulates Binge-Like Ethanol Drinking in C57BL/6J Mice via Y1 and Y2 Receptors

NEUROPSYCHOPHARMACOLOGY

IF7.1

2012-01-04

OAAI

Sparrow, Angela M.; Lowery-Gionta, Emily G.; Pleil, Kristen E.; Li, Chia; Sprow, Gretchen M.; Cox, Benjamin R.; Rinker, Jennifer A.; Jijon, Ana M.; Pena, Jose; Navarro, Montserrat; Kash, Thomas L.; Thiele, Todd E.

High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial

EUROPEAN HEART JOURNAL

IF35.6

2011-12-20

OAAI

Pena, Jessica M.; MacFadyen, Jean; Glynn, Robert J.; Ridker, Paul M.

Dengue Virus Modulates the Unfolded Protein Response in a Time-dependent Manner

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2011-04-01

175

OAAI

Pena, Jose; Harris, Eva

Obstetric and perinatal complications in HIV-infected women.: Analysis of a cohort of 167 pregnancies between 1997 and 2003

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

IF3.1

2010-12-31

OAAI

Marti, Covadonga; Pena, Jose M.; Bates, Isabel; Madero, Rosario; De Jose, Isabel; Pallardo, Luis Felipe; Arribas, Jose Ramon; Gonzalez-Garcia, Juan; Gonzalez, Antonio; Vazquez, Juan Jose

Bayesian analysis using continuous likelihood ratios for identifying pleural exudates

RESPIRATORY MEDICINE

IF3.1

2006-11-01

OAAI

Porcel, J. M.; Pena, J. M.; Vicente de Vera, C.; Esquerda, A.; Vives, M.; Light, Richard W.

Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy:: Results of an open, randomized, multicenter clinical trial

CLINICAL INFECTIOUS DISEASES

IF7.3

2006-07-01

OAAI

Miro, JM; Lopez, JC; Podzamczer, D; Peña, JM; Alberdi, JC; Martínez, E; Domingo, P; Cosin, J; Claramonte, X; Arribas, JR; Santín, M; Ribera, E

High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/μl and opportunistic diseases:: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients)

AIDS

IF3.1

2002-07-01

OAAI

Arribas, JR; Pulido, F; Miró, JM; Costa, MA; González, J; Rubio, R; Peña, JM; Torralba, M; Lonca, M; Lorenzo, A; del Palacio, A; Vázquez, JJ; Gatell, JM

Treatment of tuberculosis in HIV-infected patients:: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin

AIDS

IF3.1

2001-06-01

OAAI

Moreno, S; Podzamczer, D; Blázquez, R; Iribarren, JA; Ferrer, E; Reparaz, J; Peña, JM; Cabrero, E; Usán, L

研究方向